🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Benicar® Tablets 40 mg

Found 17 matching trials

Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

PHASE1

The objective of this study was to investigate the bioequivalence of Mylan'...

Status

Completed

Location

PRACS Institute, Ltd.

Start Date

2005-12

Trial ID

NCT00648219

Treatments Being Tested

Olmesartan Medoxomil Tablets 40 mg Benicar® Tablets 40 mg

Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

PHASE2

The purpose of this study is to determine the safety and efficacy of azilsa...

Status

Completed

Location

Multiple Locations

Start Date

2004-08

Trial ID

NCT00759551

Treatments Being Tested

Azilsartan Azilsartan Azilsartan Azilsartan Azilsartan Placebo Olmesartan

Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

PHASE1

The objective of this study was to investigate the bioequivalence of Mylan'...

Status

Completed

Location

PRACS Institute Ltd.

Start Date

2006-11

Trial ID

NCT01019590

Treatments Being Tested

Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg Benicar HCT ® Tablets 40 mg/25 mg

A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions

PHASE1

This single dose study was designed in accordance with EMA (the European Me...

Status

Unknown

Location

Altasciences Company Inc.

Start Date

2019-10-31

Trial ID

NCT04138888

Treatments Being Tested

Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use Olmetec® Plus 40 Mg/25 Mg film-coated tablets for oral use

The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.

PHASE1

This single dose study is designed in accordance with EMA (the European Med...

Status

Completed

Location

Altasciences Company Inc.

Start Date

2019-05-06

Trial ID

NCT03951051

Treatments Being Tested

Olmesartan Medoxomil 40 mg Olmetec®

Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control

PHASE3

The purpose of this study is to evaluate the non-inferiority clinical effic...

Status

Withdrawn

Location

Multiple Locations

Start Date

TBD

Trial ID

NCT02483936

Treatments Being Tested

Olmesartan medoxomil 40mg + chlorthalidone 12,5mg Olmesartan medoxomil 40mg + chlorthalidone 25mg Olmesartan 40mg + Hydrochlorothiazide 12,5mg Olmesartan 40mg + Hydrochlorothiazide 25mg

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

PHASE3

The purpose of this study is to compare the antihypertensive effect of azil...

Status

Completed

Location

Multiple Locations

Start Date

2010-01

Trial ID

NCT01033071

Treatments Being Tested

Azilsartan medoxomil and chlorthalidone Azilsartan medoxomil and chlorthalidone Olmesartan medoxomil and hydrochlorothiazide

Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension

PHASE3

The purpose of this study is to determine the efficacy and safety of azilsa...

Status

Completed

Location

Multiple Locations

Start Date

2009-03

Trial ID

NCT00846365

Treatments Being Tested

Azilsartan medoxomil and chlorthalidone Azilsartan medoxomil and chlorthalidone Olmesartan medoxomil-hydrochlorothiazide

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy

PHASE3

CS-8635 combines three widely prescribed antihypertensive medications, olme...

Status

Completed

Location

Korea University Ansan Hospital

Start Date

2013-04

Trial ID

NCT01838850

Treatments Being Tested

CS8635 20/5/12.5mg and placebo Olmetec® Plus 20/12.5mg and placebo

Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

PHASE1

The objective of this study was to investigate the bioequivalence of Mylan'...

Status

Completed

Location

PRACS Institute Ltd.

Start Date

2006-11

Trial ID

NCT01020214

Treatments Being Tested

Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg Benicar HCT® Tablets 40 mg/25 mg

Previous Next